Your browser doesn't support javascript.
loading
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC).
Bilusic, Marijo; McMahon, Sheri; Madan, Ravi A; Karzai, Fatima; Tsai, Yo-Ting; Donahue, Renee N; Palena, Claudia; Jochems, Caroline; Marté, Jennifer L; Floudas, Charalampos; Strauss, Julius; Redman, Jason; Abdul Sater, Houssein; Rabizadeh, Shahrooz; Soon-Shiong, Patrick; Schlom, Jeffrey; Gulley, James L.
Afiliación
  • Bilusic M; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA marijo.bilusic@nih.gov.
  • McMahon S; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Madan RA; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Karzai F; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Tsai YT; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Donahue RN; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Palena C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Jochems C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Marté JL; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Floudas C; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Strauss J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Redman J; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Abdul Sater H; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Rabizadeh S; ImmunityBio, Culver City, California, USA.
  • Soon-Shiong P; ImmunityBio, Culver City, California, USA.
  • Schlom J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.
  • Gulley JL; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
J Immunother Cancer ; 9(3)2021 03.
Article en En | MEDLINE | ID: mdl-33762322
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calicreínas / Adenoviridae / Antígeno Prostático Específico / Vacunas Combinadas / Mucina-1 / Vacunas contra el Cáncer / Proteínas de Dominio T Box / Proteínas Fetales / Neoplasias de la Próstata Resistentes a la Castración Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calicreínas / Adenoviridae / Antígeno Prostático Específico / Vacunas Combinadas / Mucina-1 / Vacunas contra el Cáncer / Proteínas de Dominio T Box / Proteínas Fetales / Neoplasias de la Próstata Resistentes a la Castración Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido